GSK-3β inhibitor 1_product_DataBase

CAS: 187325-53-7 F: C14H10N2O W: 222.24

GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabet

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity

GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC50 of 4.9 nM[1].

Name

GSK-3β inhibitor 1

CAS

187325-53-7

Formula

C14H10N2O

Molar Mass

222.24

Appearance

Solid

Transport

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Reference

[1]. Lozinskaya NA, et al. Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors. Bioorg Med Chem. 2019 May 1;27(9):1804-1817.

PeptideDB

GSK-3β inhibitor 1

CAS: 187325-53-7 F: C14H10N2O W: 222.24